Online marketing expenditures by pharmaceutical companies is currently scant and will remain limited in the near future, according to market researcher Jupiter Communications, Inc.
And this meager spending to enhance product-specific sites and capture consumer data may go to waste as less than 25% of online consumers would share personal information with drug makers.
Meanwhile more than 50% of health industry executives responding to a recent survey said they plan to increase their current online marketing budgets by only 25% or less in the next year. Many cited the Internet’s poor return on investment as the biggest barrier to increased spending.